Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41415-020-2228-9 http://scihub22266oqcxt.onion/10.1038/s41415-020-2228-9 33097885!7582419!33097885     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+Dent+J 2020 ; 229 (8): 521-524 Nephropedia Template TP {{tp|p=33097885|t=2020. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |pdf=|usr=}}{{33097885}} gab.com Text Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 JO: Br Dent J http://www.kidney.de/pget.php?&tw=1&pmid=33097885 #FOAvip A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good universal precautions, even for aerosol generating procedures. Viral infectivity with SARS-CoV-2 lasts eight days, unlike viral polymerase chain reaction (PCR) swab tests which can persist for as long as seven weeks. SARS-CoV-2 IgG antibody becomes detectable from 11 days after infection. SARS-CoV-2 IgG antibodies are usually neutralising against the virus and their direct antiviral activity was partially demonstrated in 33,000 patients with COVID-19 treated with convalescent plasma in the USA. So, a positive SARS-CoV-2 IgG antibody is a much more accurate determination of infectiousness than a repeat PCR which is only 70% sensitive. It remains to be seen whether SARS-Cov-2 vaccine responses include protective IgG titres and, once vaccines become widespread, can be used to assist decision-making on appropriate personal protective equipment (PPE) in dentistry. Twit Text FOAVip Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 ????Br Dent J http://www.kidney.de/pget.php?&tw=1&pmid=33097885 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33097885 #FOAvip English Wikipedia <ref>{{Cite pmid|33097885}}</ref> Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 #MMPMID33097885 Denning DW; Kilcoyne A; Ucer C Br Dent J 2020[Oct]; 229 (8): 521-524 PMID33097885show ga A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good universal precautions, even for aerosol generating procedures. Viral infectivity with SARS-CoV-2 lasts eight days, unlike viral polymerase chain reaction (PCR) swab tests which can persist for as long as seven weeks. SARS-CoV-2 IgG antibody becomes detectable from 11 days after infection. SARS-CoV-2 IgG antibodies are usually neutralising against the virus and their direct antiviral activity was partially demonstrated in 33,000 patients with COVID-19 treated with convalescent plasma in the USA. So, a positive SARS-CoV-2 IgG antibody is a much more accurate determination of infectiousness than a repeat PCR which is only 70% sensitive. It remains to be seen whether SARS-Cov-2 vaccine responses include protective IgG titres and, once vaccines become widespread, can be used to assist decision-making on appropriate personal protective equipment (PPE) in dentistry. |*Coronavirus Infections/prevention & control/therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |*Severe acute respiratory syndrome-related coronavirus[MESH] |Antibodies, Viral[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Immunoglobulin G[MESH] |SARS-CoV-2[MESH]Non-infectious status indicated by detectable IgG antibody to SARS-CoV(epmc).pdf DeepDyve Pubget Overpricing